Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma
Top Cited Papers
Open Access
- 5 April 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 25 (6), 1026-1035
- https://doi.org/10.1038/leu.2011.53
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Gene expression phenotypic models that predict the activity of oncogenic pathwaysNature Genetics, 2003
- c-Myc Sensitizes Cells to Tumor Necrosis Factor-mediated Apoptosis by Inhibiting Nuclear Factor κB TransactivationPublished by Elsevier BV ,2002
- Genomic abnormalities in monoclonal gammopathy of undetermined significanceBlood, 2002
- Multiple myeloma: evolving genetic events and host interactionsNature Reviews Cancer, 2002
- Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cellsBlood, 2002
- A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined SignificanceThe New England Journal of Medicine, 2002
- Multiple Ras-dependent phosphorylation pathways regulate Myc protein stabilityGenes & Development, 2000
- Cell cycle activation by c-myc in a Burkitt lymphoma model cell lineInternational Journal of Cancer, 2000
- c-Myc enhances protein synthesis and cell size during B lymphocyte developmentProceedings of the National Academy of Sciences of the United States of America, 1999
- Control of cell growth by c-Myc in the absence of cell divisionCurrent Biology, 1999